Review
Published on 05 Jun 2024
The treatment of follicular lymphoma with CD19-directed chimeric antigen receptor T-cell therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1384600
- 1,686 views
Type at least 3 characters
1,744 articles
Articles
Review
Published on 04 Jun 2024
Allogeneic stem cell transplantation in multiple myeloma: is there still a place?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1402106
- 1,688 views
Editorial
Published on 03 Jun 2024
Editorial: Checkpoint inhibition in hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1429854
- 565 views
Original Research
Published on 31 May 2024
LINC00958 as new diagnostic and prognostic biomarker of childhood acute lymphoblastic leukaemia of B cells
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1388154
- 971 views
Original Research
Published on 30 May 2024
Hematopoietic stem cell transplantation: an Italian monocentric experience on the health assessment and eligibility of adult-related donors
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1389068
- 786 views
Original Research
Published on 28 May 2024
Health-related quality of life in adults with hematological cancer: a 2023 cross-sectional survey from Qatar
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1391429
- 1,100 views
Case Report
Published on 28 May 2024
Case report: Difficult diagnosis of Mycobacterium tuberculosis infection in patients after allogeneic hematopoietic stem cell transplantation: two case reports and a literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1283320
- 593 views
Mini Review
Published on 21 May 2024
Mechanisms and management of CAR T toxicity
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1396490
- 3,468 views
- 2 citations
Mini Review
Published on 21 May 2024
Understanding iron homeostasis in MDS: the role of erythroferrone
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1404817
- 858 views
Original Research
Published on 21 May 2024
The impact of Bruton’s tyrosine kinase inhibitor treatment on COVID-19 outcomes in Chinese patients with chronic lymphocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1396913
- 1,106 views
Original Research
Published on 21 May 2024
A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1395992
- 1,060 views
Case Report
Published on 21 May 2024
Spinal myeloid sarcoma presenting as initial symptom in acute promyelocytic leukemia with a rare cryptic PLZF::RARα fusion gene: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1375737
- 907 views
Case Report
Published on 17 May 2024
Case report: Lymph node metastasis of pelvic alveolar rhabdomyosarcoma diagnosed by fine needle aspiration cytology
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1340865
- 754 views
Brief Research Report
Published on 17 May 2024
Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1352281
- 2,256 views
- 1 citation
Review
Published on 16 May 2024
An overview of prognostic markers in patients with CLL
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1371057
- 3,094 views
- 3 citations
Original Research
Published on 13 May 2024
Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1369601
- 799 views